Form EFFECT NLS Pharmaceutics Ltd.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 26, 2024 4:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InvenTrust Properties Announces Appointment of Robert Garechana to Board of Directors
- Seneca Foods Announces Shareholder Approval of Five-For-One Forward Stock Split
- Fall Home Maintenance Checklist for East Texas: Plumbing and HVAC Essentials Before the First Cold Snap
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share